Effect of Lipids and Obesity on Blood Glucose Level: The Connection Between Obesity and Diabetes-A Review | ||
| Egyptian Journal of Chemistry | ||
| Volume 68, Issue 13, December 2025, Pages 607-617 PDF (292.8 K) | ||
| Document Type: Review Articles | ||
| DOI: 10.21608/ejchem.2025.395260.11921 | ||
| Authors | ||
| Mohammed Nasir Almulhim1; Hani Saud Almutairi1; Mohammed Abdulrahman Almashan1; Soliman Mohammed Alchaidib* 2; Omar Obaid Alharbi2; Maysam Taysir Almegbel2; Amani Ayyadhah Alanazi2; Bander Batti Alrasheedi2; Ahlam Mohammed Alzahrani2; Nasser Ali Alhabib2; Mohammed Ahmed Almansour2; Mohammed Abdulaziz Almaniea2; Sultan Abdullah Alsubaie2; Hanadi Naji Alhajrasi2; Najlaa Saeed Alghamdi2; Wessam Ayed Aljohani2; Mohammed Abdullah Ali Al Nosyan2; Mohammed Saleh Abdulkareem Al Juma2; Ahmed Abdullah Sharkh Alsharekh2 | ||
| 1General Administration of medical services, Riyadh, Saudi Arabia | ||
| 2National Guard Health Affairs, Jeddah, Saudi Arabia | ||
| Abstract | ||
| Background: Obesity is a primary modifiable risk factor for type 2 diabetes (T2D), driven by pathophysiological mechanisms like insulin resistance and β-cell dysfunction. The global rise in obesity has correspondingly increased the prevalence of T2D, making its management a critical public health issue. Aim: This review synthesizes evidence on the connection between obesity and T2D, evaluating the efficacy of structured management strategies—including lifestyle interventions, pharmacotherapy, and metabolic surgery—for prevention, treatment, and remission. Methods: A comprehensive review of clinical trials, consensus guidelines (e.g., from the American Diabetes Association and the Second Diabetes Surgery Summit), and long-term studies was conducted. Data on weight loss, glycemic control (HbA1c), and diabetes remission rates across different interventions were analyzed. Results: Intensive lifestyle intervention (ILI) can achieve >5% weight loss and reduce diabetes incidence by over 50%. Pharmacological agents like semaglutide and tirzepatide demonstrate 15-20% weight reduction. Metabolic surgery is the most effective intervention, with HbA1c reductions of ~2% and T2D remission rates of 30-60% over 1-5 years, proving cost-effective in the long term. Conclusion: A multifaceted, guideline-directed approach is essential. ILI is the cornerstone, with pharmacotherapy and surgery providing powerful adjuncts for eligible patients. An interprofessional team is crucial for implementing these tiered strategies to reduce the burden of obesity-related diabetes. | ||
| Keywords | ||
| Obesity; Type 2 Diabetes; Insulin Resistance; Bariatric Surgery; GLP-1 Agonists; Lifestyle Intervention | ||
|
Statistics Article View: 220 PDF Download: 127 |
||